About Sympara Medical
Sympara Medical was a Healthcare company based in San Francisco (United States) founded in 2012. It develops innovative medical devices for effective hypertension treatment. It operates on a B2B model. Sympara Medical has raised $4.25 million across 1 funding round. The company is recorded as dissolved. Its focus areas include Medical Devices, Treatment Devices and Hypertension Solutions. Its competitors include Valencia Technologies, Third Pole Therapeutics and Rox Medical; 3 of its 3 listed competitors have raised funding.
Company details
Sympara Medical develops innovative medical devices for effective hypertension treatment through providing healthcare solutions, developing medical devices, treatment devices, and hypertension solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters San Francisco, United States
- SectorsHealthcare
- Website sympara.com
- Total Equity Funding$4.25M (USD)
in 1 rounds
- Latest Funding Round$4.25M (USD), Series A
Apr 2013
Funding Insights of Sympara Medical
Sympara Medical has successfully raised a total of $4.25M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.25 million completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.25M
- Total Rounds 1
- Last Round Series A — $4.25M
- First Round $4.25M
(Apr 2013)
All 1 funding rounds of Sympara Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2013 | $4.25M | Series A | – | – | – |
Timeline of Sympara Medical
2 dated milestones of Sympara Medical across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Sympara Medical is founded.
- Funding First funding round of $4.2M.
Competitors of Sympara Medical
Sympara Medical has 3 listed competitors in our database, 3 of them funded. They include Valencia Technologies, Third Pole Therapeutics and Rox Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| valenciatechnologies.com | 2011 | Santa Clarita, United States | $54.97M | A coin-sized neuromodulation device for hypertension treatment is developed. | ||
| pole3.com | 2014 | Boston, United States | $87.6M | Developer of devices for cardiopulmonary therapies | ||
| roxmedical.com | 2004 | San Clemente, United States | $101.1M | 6 | Develops interventional vascular therapies. |
Detailed competitors of Sympara Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Sympara Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sympara Medical
Sympara Medical was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Sympara Medical is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Sympara Medical is a funded company, having raised a total of $4.25M across 1 funding round to date. The company's 1st funding round was a Series A of $4.25M, raised on Apr 2013.
Sympara Medical develops innovative medical devices for effective hypertension treatment through providing healthcare solutions, developing medical devices, treatment devices, and hypertension solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Sympara Medical's top competitors include Valencia Technologies, Third Pole Therapeutics and Rox Medical.